FDAnews
www.fdanews.com/articles/147433-teva-introduces-generic-equivalent-of-symbyax-in-u-s

Teva Introduces Generic Equivalent of Symbyax in U.S.

June 22, 2012
Teva Pharmaceutical has launched Olanzapine and Fluoxetine Capsules USP 6mg/25mg, 12mg/25mg, 6mg/50mg and 12mg/50mg. The olanzapine and fluoxetine capsules are the company’s generic equivalent to Symbyax.
Pharmaceutical Business Review